GPT and metabolic dysfunction-associated steatotic liver disease: Using the lowest SUA quartile as reference, the ORs for NAFLD was 1.95 (95% CI 1.16–3.31), 3.08 (95% CI 1.85–5.14), and 2.81 (95% CI 1.66–4.76) for quartiles 2, 3, and 4, respectively (P<0.001 for trend), after further adjusting for HOMA-IR, CRP, creatinine, ALT and components of metabolic syndrome (model 5).